Researchers from McMaster University and the Firestone Institute for Respiratory Health at St. Joseph’s Healthcare Hamilton, together with colleagues at other partnering institutions, have developed a new method to treat severe asthma.
In a study of over 200 participants with severe asthma, the new treatment was shown to have improved asthma symptoms and lung function, while reducing the need for corticosteroids by up to 70%.
According to Statistics Canada, eight per cent of Canadians aged 12 or older – approximately 2.4 million people – have been diagnosed with asthma. Of that, approximately 25% are considered to be severe cases of asthma.
Current treatments for severe asthma often include high doses of corticosteroids, such as prednisone, to control exacerbations. Reducing the need for corticosteroids with alternative treatments is preferable, since these medications are associated with serious side effects from prolonged use – including multi-organ toxicities and immunosuppression.
Parameswaran Nair, professor of medicine at McMaster and staff respirologist at St. Joseph’s Healthcare Hamilton, along with a team of researchers found that an antibody called dupilumab is effective in treating severe asthma in place of high doses of prednisone.
The results were published in the New England Journal of Medicine, one of the world’s most influential medical publications.
Researchers sought participants who had been using oral corticosteroids (prednisone) to treat severe asthma for at least six months prior to the study. In addition to their standard regimen of corticosteroids, patients received either dupilumab or a placebo during the 24 week trial. The corticosteroid dose was gradually reduced during weeks four to 20, and maintained at a low level for the final four weeks.
“The ability of dupilumab to increase lung function as markedly as it did in this study, even in the face of [corticosteroid] withdrawal, indicates that it appears to be inhibiting key drivers of lung inflammation,” the researchers noted.
Dupilumab works to treat asthma by blocking two specific proteins (called interleukin-4 and interleukin-13) that are associated with inflammation of the airways.
This technique was based on Nair’s previous research, (published in the New England Journal of Medicine in 2009 and in 2017). Those studies found that blocking another protein, interleukin-5, allowed patients with high eosinophil levels in their blood and airways to reduce their corticosteroid dose. Eosinophils are a type of white blood cell involved with the production of interleukins. High eosinophil levels are directly linked to an increased risk of severe asthma.
Unlike the previous studies, dupilumab was shown to be effective regardless of patients’ eosinophil levels. Despite the reduced prednisone dose, patients in this study not only experienced a decrease in asthma exacerbations, but their lung function also improved significantly.
“Ultimately, our goal is to find new treatment pathways that allow us to circumvent the use of corticosteroids,” said Nair.
“Since dupilumab showed a significant improvement on asthma control regardless of eosinophil levels, we may be able to use this treatment for a wider range of patients than we previously thought possible. This might be due to the broad effects on inflammation in asthma of the two proteins that we were able to block with dupilumab. The treatment was not associated with any serious side effects.”
The Latest on: Asthma
via Google News
The Latest on: Asthma
- Norton teen begins therapy after asthma attack at homecoming danceon November 29, 2019 at 2:43 pm
Emma Pfouts has been moved into a cardiac chair and is set to begin physical therapy after suffering an asthma attack at the North High School homecoming dance.
- What Is Severe Asthma?on November 28, 2019 at 6:21 am
Severe asthma is a form of the condition that isn't easily controlled, says Dr. Thomas Slobig, an adult pulmonary physician in private practice in Gilbert, Arizona. Nationwide, more than 25 ...
- Asthma Control Is Critical During Pregnancyon November 27, 2019 at 4:37 pm
Pregnant women with asthma should take special care to keep their asthma in check. Canadian researchers have found that asthma attacks during pregnancy are associated with a number of serious health ...
- Asthma exacerbations may worsen pregnancy outcomeson November 27, 2019 at 10:32 am
(HealthDay)—For women with asthma, asthma exacerbation (AE) during pregnancy is associated with an increased risk for pregnancy complications, adverse perinatal outcomes, and early childhood ...
- Asthma Drugs Market Size, Share, Trend, Future Demand Analysis by 2019-2023 | Pfizer, GlaxoSmithKline, Novartis, Merckon November 27, 2019 at 8:15 am
Nov 27, 2019 (Reporthive Research via COMTEX) -- Chicago, United States, Nov 27, 2019 -- Report hive adds Asthma Drugs Market report to its research database. Delivering in depth market statistics, ...
- The Use of Heated Tobacco Products is Associated with Asthma, Allergic Rhinitis, and Atopic Dermatitis in Korean Adolescentson November 27, 2019 at 2:07 am
Multiple tobacco use had an association with the risk of each allergic disease. Use of each tobacco product was significantly associated with an increased risk of multi-morbidity of asthma, allergic ...
- Women with severe asthma more likely to develop pre-eclampsia, study showson November 26, 2019 at 4:01 pm
Pregnant woman with asthma Pregnant women with severe asthma are more likely to develop life-threatening pre-eclampsia, a Canadian study has shown. The research, found that women who suffered from ...
- Asthma Medication Market 2019 Global Industry Share, Demand, Top Players, Industry Size, Future Growth by 2025: Research Reports Worldon November 25, 2019 at 8:52 pm
Nov 26, 2019 (The Expresswire) -- Asthma Medication Industry 2019 Global Market research report provides key analysis on the market status of the Asthma Medication manufacturers with market size, ...
- FeNO may help diagnose cough variant asthmaon November 25, 2019 at 10:24 am
Forced exhaled nitric oxide, or FeNO, may be useful for diagnosing cough variant asthma in patients with chronic cough who have normal spirometry, researchers reported at the American College of ...
via Bing News